Credit: CC0 Public Domain
Three studies have been published today SNIS (Society of Neurointerortional Surgery) 22nd annual meeting The use of GLP-1 inhibitors can reduce the impact of stroke and related brain damage, or discuss whether the risk of stroke can be reduced. The drug, which lowers blood sugar and often causes weight loss, is generally prescribed in type 2 diabetes and obesity and contains drugs such as semaglutide (ozempic).
In the first study, “Ozempic influence on the mortality and survival of patients with acute ischemic stroke: National and institutional post -fragrant analysis,” University of Wisconsin -Madison -Madison uses the university medical center and the world’s health collaboration in Ozempic I saw the person who checked the strokic better.
In the global data set, 2,021,704 patients who experienced a stroke, 43,338 people were in Ozempic, and the Wisconsin University Data Set used 13,510 people who experienced stroke, and 190 of them used Ozempic. The deaths caused by stroke were lower for two cohort Ozbig users.
In the global data set, 5.26%of Ozempic users died of a stroke compared to 21.61%of non -users, and Ozempic users accounted for 77.5%in the long run, compared to 30.95%of non -initial users, with a 77.5%chance of stroke. The university cohort showed similar results, similar to that of 5.26%of Ozempic users died of stroke and 26.57%of patients who did not use Ozempic.
In the second study, the University of Wisconsin -University of Wisconsin – Madison “The connection between the use of Ozvic and the Risk of Stroke: National Emergency Analysis” researchers surveyed the large -scale national emergency room records for those who have experienced stroke and those who use Ozfixes. They discovered the connection between potential Oz pick users and significantly reduced the probability of stroke. The research team is much more accurate in the relationship between Ozempic and stroke prevention by directly evaluating data at the pharmacy through this study.
The third study, “Influence of GLP-1 agents on the stroke of the GLP-1 agent, the influence of GLP-1 agents on SAH and ICH: Provision-Institutional Cohort Study” was presented by researchers from Galveston’s Texas University Medical Branch. They investigated whether GLP-1 inhibitors could improve the results of brain bleeding (both patients with voluntary bleeding and brain aneurysms) and after stroke.
After reviewing the patient records of 6 and 12 months after each brain bleeding, the team found that one and two years after each stroke, the use of GLP-1 inhibitors was associated with cerebral hemorrhage and stroke side effects, seizures, future brain bleeding and death.
According to AHMED Elbayomy, MD, a researcher and data scientist at the Department of Neurophysics at the University of Wisconsin -Madison, this result is very promising.
Elbayomy said, “We need more research, but seeing the potential protection provided by this drug is a fascinating discovery.
Matias Costa, a neurosurgery department at the University of Texas, said, “This study can introduce a new perspective on preventing and alleviating and alleviating the fatal effects of stroke and related brain damage.
Provided by the Neurological Surgery Society
recallBody weight loss drugs, such as Ozempic, can help prevent stroke and reduce brain damage complications.
This document is copyrighted. In addition to fair transactions for individual research or research purposes, no part can be reproduced without written permission. The contents are provided only for information purposes.
